We showed that CP-Hepatocytes over a period of 16 weeks transformed into cells expressing high levels of markers for HCC (Glypican-3 (GPC3) and α Smooth Muscle Actin (α-SMA) and cell proliferation nuclear antigen (PCNA). The gene discussed is GPC3; the disease is hepatocellular carcinoma.